Equitec Proprietary Markets, LLC Seagen Inc. Call Options Transaction History

Equitec Proprietary Markets, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Oct 17, 2023	BUY	$191.51 - $216.16 $25.9 Million - $29.3 Million	135,500 Added 852.2%	151,400 $32.1 Million
Q2 2023 Jul 12, 2023	SELL	$187.64 - $206.25 $900,671 - $990,000	-4,800 Reduced 23.19%	15,900 $3.06 Million
Q1 2023 Apr 28, 2023	BUY	$127.59 - $203.08 $2.64 Million - $4.2 Million	20,700 New	20,700 $4.19 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.